References
- McKenna R W, Washington L T, Acquino D B, Picker L J, Kroft S H. Immunophenotypic analysis of hematogones (B-lymphocyte precursors) in 662 consecutive bone marrow specimens by 4-color flow cytometry. Blood 2001; 98: 2498–2507
- Babusikova O, Zeleznikova T, Kirschnerova G, Kankuri E. Hematogones in acute leukemia during and after therapy. Leuk Lymphoma 2008; 49: 1935–1944
- Chen W, Karandikar N J, McKenna R W, Kroft S H. Stability of leukemia-associated immunophenotypes in precursor B-lymphoblastic leukemia/lymphoma: a single institution experience. Am J Clin Pathol 2007; 127: 39–46
- Rimsza L M, Larson R S, Winter S S, Foucar K, Chong Y Y, Garner K W, Leith C P. Benign hematogone-rich lymphoid proliferations can be distinguished from B-lineage acute lymphoblastic leukemia by integration of morphology, immunophenotype, adhesion molecule expression, and architectural features. Am J Clin Pathol 2000; 114: 66–75
- Sevilla D W, Emmons FN, Bai X, Colovai A, Bhagat G, Alobeid B. The pattern of cytoplasmic IgM expression in the context of the three currently recognised maturational stages of hematogones. Leuk Lymphoma 2009; 50: 642–644
- WHO classification of tumours of haematopoietic tissue and lymphoid tissues, SH CE Swerdlow, NL Harris, SA Pileri, H Stein, J Thiele, JW Vardiman. International Agency for Research on Cancer (IARC), LyonFrance 2008